Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: A novel anti-tumor agent

Cancer Biotherapy and Radiopharmaceuticals

Volumn 12, Issue 1, 1997, Pages 37-45

  Saltzman, Daniel A ^a   Katsanis, Emmanuel ^a   Heise, Charles P ^a   Hasz, Diane E ^a   Kelly, Sandra M ^b   Curtiss III, Roy ^c   Leonard, Arnold S ^a   Anderson, Peter M ^d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Megan Health   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; FEEDING; FEMALE; LIVER HOMOGENATE; LIVER METASTASIS; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SPLEEN;

EID: 0030947948     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1997.12.37     Document Type: Article

References (25)

1. Parker SL, Tong T, Bolden S, and Wingo PA. Cancer Statistics 1996;46(1):5-28.
2. Blumgart LH and Fong Y. Surgical Options in the Treatment of Hepatic Metastases from Colorectal Cancer. Current Problems in Surgery 1995;32(5):333-428.
3. Anderson PM and Sorenson MA. Interleukin-2: Effects of Route and Formulation on Clinical Pharmacokinetics Clinical Pharmacokinetics 1994;27(1)19-31.
4. WhittingtonR and Faulds D. Interleukin-2: A Review of its Pharmacologic Properties and Therapeutic Use in Patients with Cancer. Drugs 1993;46(3):446-514
5. Dunlap NE, Benjamin Jr. WH, McCall Jr. RD, Tilden AB, and Briles DE. A 'Safe-Site' of Salmonella typhimurium is within Splenic Cells during the Early Phase of Infection in Mice. Microbial Pathogenesis 1991;10:297-310
6. Carter PB and Collins FM. The Route of Enteric Infection in Normal Mice. J Exp Med 1974;139.1189-1203.
7. Curtiss, III. R, and Kelly SM Salmonella typhimurium Deletion Mutants Lacking Adenylate Cyclase and Cyclic AMP Receptor Protein Are Avirulent and Immunogenic. Infection and Immunity 1987;55(12):3035-3043
8. + Expression-cloning vector: Stable Maintenance and High Level of Expression of Cloned Genes in a Salmonella vaccine Strain. Biotechnology 1988;6:693-697.
9. Saltzman DA, Heise CP, Hasz DE, Zebede M, Kelly SM, Curtiss III R, Leonard AS, and Anderson PM. Attenuated Salmonella typhimurium Containing Interleukin-2 Decreases MC-38 Hepatic Metastases: A Novel Anti-tumor Agent. Cancer Biotherapy and Radiopharmaceuticals 1996;11(2):145-153.
10. Sambrook J, Fritsch EF, and Maniatis T. Molecular Cloning: A Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory Press, 1989.
11. Hawk CT and Leary SL. Formulary for Laboratory Animals. Iowa State University Press; 1995.
12. Veterinary Procedures Manual. Research Animal Resources of the University of Minnesota; 1994.
13. Benjamin WH, Hall P, Roberts SJ, and Briles DE. The Primary Effect of the Ity Locus is on the Rate of Growth of Salmonella typhimurium that are relatively protected from Killing. Journal of Immunology. 1990:144(8):3143-3151.
14. Maskell DJ and Hormaeche CE. Relapse Following Cessation of Antibiotic Therapy for Mouse Typhoid in Resistant and Susceptible Mice Infected with Salmonellae of Differing Virulence. Journal of Infectious Disease 1985;152(5):1044-1049.
15. Foster HL, Small JD, and Fox JG. The Mouse in Biomedical Research, Volume II. Academic Press;1982:2-7.
16. Buchwald DS and Blaser MJ. A Review of Human Salmonellosis: II. Duration of Excretion Following Infection with Nontyphi Salmonella. Reviews of Infectious Disease 1984;6(3):345-356.
17. Lahdevirta J. Ciprofloxacin in the Elimination of Enteric Salmonella Carrier Stage. Scand J Infect Dis, Suppl. 1989;60:112-115.
18. Carlstedt G, Dahl P, Niklasson PM, Gullberg K, Banck G, and Kahlmeter G. Norfloxacin Treatment of Salmonellosis Does Not Shorten the Carrier Stage Scand J Infect Dis 1990; 22:553-556.
19. Kazemi M, Gumpert TG, and Marks MI A Controlled Trial Comparing Sulfamethoxazole-Trimethoprim, Ampicillin, and No Therapy in the Treatment of Salmonella Gastroenteritis in Children. Pediatric Pharmacology and Therapeutics 1973;83(4):646-650.
20. Doggett TA and Curtiss III R Delivery of Antigens by Recombinant Avirulent Salmonella Strains. Genetically Engineered Vaccines. J.E. Ciardi et al eds Plenum Press. 1992, 165-173.
21. Schodel F, Kelly SA, Peterson DL, Milich DR, and Curtiss III, R. Hybrid Hepatitis B Virus Core-Pre-S Proteins Synthesized in Avirulent Salmonella typhimurium and Salmonella typhi for Oral Vaccination. Infection and Immunity 1994;62(5):1669-1676.
22. AnJam Khan CM, Villarreal-Ramos B, Pierce RJ, Demarco de Hormaeche R, McNeill H, Ali T, Chatfield S, Capron A, Dougan G, and Hormaeche CE. Construction, Expression, and Immunogenicity of Multiple Tandem Copies of Schistosoma mansoni Peptide 11-131 of the P28 Glutathione S-Transferase Expressed as C-Terminal Fusions to Tetanus Toxin Fragment C in a Live Aro-Attenuated Vaccine Strain of Salmonella. Journal of Immunology 1994;153:5634-5642
23. Redman TK, Harmon CC, and Michalek SM. Oral Immunization with Recombinant Salmonella typhimurium Expressing Surface Protein Antigen A of Streptococcus sobrinus: Persistence and Induction of Humoral Responses in Rats. Infection and Immunity 1994,62(8):3162-3171
24. Tacket CO, Hone DM, Curtiss III R, Kelly SM, Losonsky G, Guers L, Harris AM, Edelman R, and Levine MM. Comparison of the Saftey and Immunogenicity of DaroC DaroD and Dcya Dcrp Salmonella typhi Strains in Adult Volunteers. Infection and Immunity1992;60(2):536-541.
25. Lafreniere R and Rosenberg SA. A Novel Approach to the Generation and Identification of Hepatic Metastases in a Murine Model. JNCI 1986,76(2):309-322.